Not medical or dosing advice, and not for human or veterinary use
Yes, your health data stays private and secure on your device
In this 54-month study, an estimated 12,500 participants with type 2 diabetes and confirmed atherosclerotic heart disease will be randomized into two groups and treated with either tirzepatide or dulaglutide (more commonly known as Trulicity)
The study found that in a pool of 16,827 patients, nonarteritic anterior ischemic optic Neuropathy (NAION) increased more than four times for people taking semaglutide compared to those who took another drug
Hepatic Lipid Metabolism: Studying alterations in liver tissue, specifically focusing on the down-regulation of lipid accumulation and modifications to hepatic gluconeogenesis pathways
Wound Repair and Regeneration , 18(5), 537-545